ADIPOQ and endometrial cancer: In contrast to BMI, ASAT, and liver fat, we found that higher genetically predicted GFAT increases adiponectin levels, which then may protect from non-endometrioid endometrial cancer development, thus in part explaining a potential protective effect of GFAT on non-endometrioid endometrial cancer risk.